Table 1.
Parameters | All | Cystectomy | p Value | |
---|---|---|---|---|
No | Yes | |||
Total no. of patients | 343 | 291 | 52 | |
Total no. of measurements | 1185 | 963 | 222 | |
Measurements per person | 3.4 | 3.3 | 4.2 | |
Age (years); mean ± SD | 67.0 ± 10.5 | 67.0 ± 11.8 | 67.7 ± 9.4 | 0.61 |
Age group | 0.19 | |||
≥70 y/o | 144 | 123 | 21 | |
60–69 y/o | 99 | 79 | 20 | |
<60 y/o | 100 | 89 | 11 | |
Gender (male/female) | 238/105 | 192/88 | 46/17 | 0.59 |
Disease status (N) | <0.0001 | |||
NMIBC | 234 | 224 | 10 | |
MIBC or more severe condition | 109 | 67 | 42 | |
Measurements per person | Not assessed | |||
NMIBC | 3.4 | 3.4 | 3.6 | |
MIBC or more severe condition | 3.6 | 3.1 | 4.0 | |
Education (years) | 9.0 ± 4.7 | 9.0 ± 4.8 | 9.1 ± 4.6 | 0.93 |
Marital status (married or cohabiting/other) | 250/93 | 218/73 | 32/20 | 0.04 |
Monthly family income >USD 1750 (yes/no/missing) | 106/229/7 | 94/192/5 | 12/37/2 | 0.24 |
Months since first treatment (median, quartile deviation) | 14.6 (30.0) | 14.5 (30.3) | 14.9 (27.5) | - |
Comorbidity | ||||
Diabetes mellitus | 61 (17.8%) | 58 (19.9%) | 3 (5.8%) | 0.01 |
Heart Disease | 39 (11.4%) | 37 (12.7%) | 2 (3.8%) | 0.06 |
Other malignancies | 12 (3.5%) | 7 (2.4%) | 5 (9.6%) | 0.01 |
Systemic chemotherapy in the past year | 17 (5.0%) | 13 (4.5%) | 4 (7.7%) | 0.32 |
Radiotherapy | 11 (3.2%) | 10 (3.4%) | 1 (1.9%) | 0.57 |
NMIBC, non-muscle-invasive bladder cancer; MIBC, muscle-invasive bladder cancer; SD, standard deviation; USD, United States dollar.